scholarly journals Imagiological Diagnosis of Gastrointestinal Diseases – Diagnostic Criteria of Hepatocellular Carcinoma

2015 ◽  
Vol 22 (4) ◽  
pp. 153-160 ◽  
Author(s):  
Pedro Boal Carvalho ◽  
Eduardo Pereira
2021 ◽  
Vol 17 (6) ◽  
pp. 409-413
Author(s):  
Yi‐Te Lee ◽  
Jasmine J. Wang ◽  
Yazhen Zhu ◽  
Vatche G. Agopian ◽  
Hsian‐Rong Tseng ◽  
...  

Dose-Response ◽  
2020 ◽  
Vol 18 (2) ◽  
pp. 155932582090753
Author(s):  
Hsiu C. Lin ◽  
Huan Y. Hsu ◽  
Hsiu L. Lin ◽  
Yow S. Uang ◽  
Yi Ho ◽  
...  

Background: Acid-suppressive agents (ASAs), which are mostly used in patients with upper gastrointestinal diseases (UGIDs), may influence the risk of hepatocellular carcinoma (HCC). Methods: A population-based retrospective cohort study was conducted. Patients with UGID who used ASAs and those who did not receive ASAs were identified. Patients without UGIDs were randomly selected and matched (comparison group). All groups were followed up for 6 years. A Cox proportional hazard model was used to estimate the risk of HCC among the different groups. Results: Patients with UGID who used ASAs had a significantly elevated HCC risk (adjusted hazard ratio [HR] 1.53; 95% confidence interval [CI], 1.32-1.76] compared to those who did not use ASAs. Patients with UGID who used more than 540 defined daily doses of ASAs had a significantly higher risk of HCC (adjusted HR 2.04; 95% CI, 1.62-2.58). Moreover, the dose effect on HCC risk exhibited a significant increasing trend ( P < .01). Furthermore, patients with UGID who did not use ASAs had a significantly elevated HCC risk (adjusted HR 1.94; 95% CI, 1.59-2.36) compared to the comparison group. Conclusion: The use of ASAs increased the risk of HCC in patients with UGIDs, and the effect of ASAs was dose dependent. In addition, UGIDs alone increased the risk of HCC.


2011 ◽  
Vol 31 (10) ◽  
pp. 1468-1476 ◽  
Author(s):  
Sung Eun Kim ◽  
Han Chu Lee ◽  
Ju Hyun Shim ◽  
Hyun Joo Park ◽  
Kang Mo Kim ◽  
...  

2018 ◽  
Vol 36 (3) ◽  
pp. 228-235 ◽  
Author(s):  
Xiao-wen Huang ◽  
Bing Liao ◽  
Yang Huang ◽  
Jin-yu Liang ◽  
Quan-yuan Shan ◽  
...  

Aim: To confirm whether cirrhosis is indispensable for the non-invasive diagnostic criteria for hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-endemic areas. Methods: Between January 2014 and December 2014, a total of 409 patients with pathologically proven focal liver lesions who underwent contrast-enhanced ultrasound (CEUS) were recruited from our institution. Clinical liver cirrhosis, HBV/HCV infection and HCC-typical vascular pattern of the targeted lesion on CEUS were evaluated. The following 3 criteria were applied to these patients to diagnose HCC: criterion 1, clinical liver cirrhosis and HCC-typical vascular pattern; criterion 2, HBV/HCV infection and HCC-typical vascular pattern; criterion 3, HBV/HCV infection or clinical liver cirrhosis and HCC-typical vascular pattern. Pathological reports were considered the gold standard. Results: A total of 311 patients had confirmed HCC by pathology. The sensitivity, specificity, accuracy, positive predictive value, negative predictive value and area under the ROC curve for criterion 1 were 29.6, 90.8, 44.3, 91.1, 28.9, and 0.60% respectively. For criterion 2, they were 83.3, 74.5, 81.2, 91.2, 58.4, and 0.79%, respectively, and for criterion 3, they were 86.2, 72.5, 82.9, 90.9, 62.3, and 0.79% respectively. Conclusions: In HBV-endemic areas, when using the HBV/HCV infection instead of cirrhosis as the precondition of the non-invasive diagnostic criteria for HCC, we should be aware of the potential false positive. Cirrhosis still plays an important role in the non-invasive diagnostic criteria for HCC because of the high specificity.


Sign in / Sign up

Export Citation Format

Share Document